SCHEMBL7019482

SCHEMBL7019482

CCc1ncccc1C(=O)N1CCC(c2cc(CN)ccc2O)CC1.c1cc2cc-2c1

nearest known ligand 0.43

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TPSAB1 Q15661 10/20 0.40
CYP2C19 P33261 2/20 0.40
KCNH2 Q12809 2/20 0.40
CYP2C9 P11712 1/20 0.40
F10 P00742 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
KDM4E B2RXH2 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4404747 0.99 TPSAB1 (0.40) TPSAB1CYP2C19KCNH2CYP2C9F10
SCHEMBL4399231 0.91 TPSAB1 (0.40) TPSAB1CYP2C19KCNH2CYP2C9F10
SCHEMBL4412828 0.90 TPSAB1 (0.49) TPSAB1CYP2C19KCNH2CYP2C9F10
Hydrochloric Acid SCHEMBL4401946 0.90 TPSAB1 (0.40) TPSAB1CYP2C19KCNH2CYP2C9F10
Hydrochloric Acid SCHEMBL4414531 0.90 TPSAB1 (0.49) TPSAB1CYP2C19KCNH2CYP2C9F10
Hydrochloric Acid SCHEMBL4404473 0.85 TPSAB1 (0.54) TPSAB1KCNH2F10CYP3A4CYP2D6
SCHEMBL7025355 0.84 TPSAB1 (0.44) TPSAB1KCNH2F10CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL4403358 0.83 TPSAB1 (0.43) TPSAB1KCNH2F10CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL6491184 0.81 TPSAB1 (0.43) TPSAB1KCNH2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL4405734 0.79 CYP2C19 (0.38) TPSAB1CYP2C19KCNH2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296972-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS Aventis Pharmaceuticals Inc. (US) 2003-04-02 EP disclosed
WO-2001090101-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2001-11-29 WO disclosed